CHANGMAO BIOCHEMICAL ENGINEERING COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.41 HKD | 0.00% |
|
+5.13% | -30.51% |
| Mar. 26 | Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 29 | Changmao Biochemical Engineering to Swing to Loss in 2023 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Changmao Biochemical Engineering Company Limited is a Hong Kong-based investment holding company principally engaged in the production and sales of organic acids. The main products of the Company include organic acids and their derivatives with four carbons in structures. Its products include fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L-tartaric acid, D-tartaric acid, DL-tartaric acid, L-aspartic acid and aspartame. Its products are mainly sold to food additive industries, chemical industries and pharmaceutical industries. The Company operates businesses in Mainland China, Europe, Asia Pacific, America and other regions.
Sector
Commodity Chemicals
Calendar
2024-08-14
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -30.51% | 27.76M | |
| +2.80% | 103B | |
| +1.20% | 67.05B | |
| +44.29% | 40.4B | |
| +15.99% | 38.64B | |
| +3.89% | 32.41B | |
| +6.82% | 19.17B | |
| +12.32% | 16.76B | |
| +17.69% | 15.07B | |
| +8.31% | 14.82B |
- Stock Market
- Equities
- 954 Stock
- News Changmao Biochemical Engineering Company Limited
- Changmao Biochemical Sees Rise in FY22 Profit
